1. Home
  2. LEXX vs LEE Comparison

LEXX vs LEE Comparison

Compare LEXX & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • LEE
  • Stock Information
  • Founded
  • LEXX 2004
  • LEE 1890
  • Country
  • LEXX Canada
  • LEE United States
  • Employees
  • LEXX N/A
  • LEE N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • LEE Newspapers/Magazines
  • Sector
  • LEXX Health Care
  • LEE Consumer Discretionary
  • Exchange
  • LEXX Nasdaq
  • LEE Nasdaq
  • Market Cap
  • LEXX 49.3M
  • LEE 53.9M
  • IPO Year
  • LEXX N/A
  • LEE N/A
  • Fundamental
  • Price
  • LEXX $3.06
  • LEE $14.79
  • Analyst Decision
  • LEXX Strong Buy
  • LEE
  • Analyst Count
  • LEXX 2
  • LEE 0
  • Target Price
  • LEXX $11.00
  • LEE N/A
  • AVG Volume (30 Days)
  • LEXX 92.3K
  • LEE 58.3K
  • Earning Date
  • LEXX 11-18-2024
  • LEE 12-05-2024
  • Dividend Yield
  • LEXX N/A
  • LEE N/A
  • EPS Growth
  • LEXX N/A
  • LEE N/A
  • EPS
  • LEXX N/A
  • LEE N/A
  • Revenue
  • LEXX $411,019.00
  • LEE $616,815,000.00
  • Revenue This Year
  • LEXX $82.02
  • LEE N/A
  • Revenue Next Year
  • LEXX $95.09
  • LEE N/A
  • P/E Ratio
  • LEXX N/A
  • LEE N/A
  • Revenue Growth
  • LEXX 34.05
  • LEE N/A
  • 52 Week Low
  • LEXX $0.90
  • LEE $7.56
  • 52 Week High
  • LEXX $6.85
  • LEE $16.49
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 45.40
  • LEE 75.94
  • Support Level
  • LEXX $2.92
  • LEE $8.54
  • Resistance Level
  • LEXX $3.39
  • LEE $16.49
  • Average True Range (ATR)
  • LEXX 0.19
  • LEE 0.99
  • MACD
  • LEXX -0.01
  • LEE 0.77
  • Stochastic Oscillator
  • LEXX 31.12
  • LEE 78.70

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH has the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. The Company has four reportable segments: Intellectual Property Licensing, B2B Production, Research and Development and Corporate. It earns maximum revenue from Intellectual Property Licensing.

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high quality, trusted, intensely local news, information, advertising and marketing services. Its product portfolio includes digital subscription platforms, daily, weekly and monthly newspapers and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and its content and advertising is available in real time through the websites and mobile apps.

Share on Social Networks: